GPI antibody

Synonyms:GPI antibody, AMF antibody, GNPI antibody, NLK antibody, PGI antibody
Catalogue No.:FNab10496Reactivity:Human
Host:MouseTested Application:ELISA, WB, IHC, IF
Clonality:monoclonalIsotype:IgG1
  • SPECIFICATIONS
Product Name
GPI antibody
Catalogue No.
FNab10496
Size
100μg
Form
liquid
Purification
Protein A+G purification
Purity
≥95% as determined by SDS-PAGE
Clonality
monoclonal
Isotype
IgG1
Clone ID
4F11
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
Glucose-6-phosphate isomerase
Alternative Names
GPI antibody, AMF antibody, GNPI antibody, NLK antibody, PGI antibody
UniProt ID
P06744
Observed MW
55-64 kDa
Application
Tested Applications
ELISA, WB, IHC, IF
Recommended dilution
WB: 1:2000-1:20000; IHC: 1:200-1:1000; IF: 1:50-1:200
Validated Images
HeLa cells were subjected to SDS PAGE followed by western blot with FNab10496(GPI antibody) at dilution of 1:5000
Immunohistochemistry of paraffin-embedded human lung cancer tissue slide using FNab10496(GPI antibody) at dilution of 1:500
Background
This gene encodes a member of the glucose phosphate isomerase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In the cytoplasm, the gene product functions as a glycolytic enzyme (glucose-6-phosphate isomerase) that interconverts glucose-6-phosphate and fructose-6-phosphate. Extracellularly, the encoded protein (also referred to as neuroleukin) functions as a neurotrophic factor that promotes survival of skeletal motor neurons and sensory neurons, and as a lymphokine that induces immunoglobulin secretion. The encoded protein is also referred to as autocrine motility factor based on an additional function as a tumor-secreted cytokine and angiogenic factor. Defects in this gene are the cause of nonspherocytic hemolytic anemia and a severe enzyme deficiency can be associated with hydrops fetalis, immediate neonatal death and neurological impairment. Alternative splicing results in multiple transcript variants.